1 story in this blend

Laboratory tests at the University of California, Berkeley revealed that a historical chemical compound called TOFA reduces fat synthesis while triggering genes that burn lipids. When administered alongside current GLP-1 medications, the combination achieved greater reductions in body weight and blood fats in animal models than standard therapy alone.